Susceptibility to SLE in South Indian Tamils may be influenced by genetic selection pressure on TLR2 and TLR9 genes

Molecular Immunology

Volumn 64, Issue 1, 2015, Pages 123-126

  Devaraju, Panneer ^a   Gulati, Reena ^a   Antony, Paul T ^a   Mithun, C B ^a   Negi, Vir S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Autoantibodies; Polymorphism; Selection pressure; SLE; TLR

Indexed keywords

AUTOANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SELECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TAMIL (PEOPLE); WILD TYPE; CASE CONTROL STUDY; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; IMMUNOLOGY;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9;

EID: 84920100018     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.11.005     Document Type: Article

References (40)

1. Aditya K.P., Sarit S.P., Rina T., Bidyut K.D. TLR-9 promoter polymorphisms (T-1237C and T-1486C) are not associated with systemic lupus erythematosus: a case control study and meta-analysis. Hum. Immunol. 2013, 74:1672-1678.
2. Arpita M., Amita A. Lack of association of single nucleotide polymorphisms in toll-like receptors 2 and 4 with enthesitis-related arthritis category of juvenile idiopathic arthritis in Indian population. Rheumatol. Int. 2013, 33:417-421.
3. Bauer S., Pigisch S., Hangel D., Kaufmann A., Hamm S. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8and 9. Immunobiology 2008, 213:315-328.
4. Berg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002, 23:509-512.
5. Berkun Y., Zandman G.G., Barzilai O., Boaz M., et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009, 18:1129-1135.
6. Biswas D., Gupta S.K., Sindhwani G., Patras A. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res. Notes 2009, 18:16.
7. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35:630-640.
8. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 2005, 202:321-331.
9. Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Parks C.G., Gilkeson G.S. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998, 41:1714-1724.
10. Davoodi H., Seow H.F. Variant toll-like receptor4 (Asp299Gly and Thr399Ile Alleles) and toll-like receptor 2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran. J. Allergy Asthma Immunol. 2011, 10:91-99.
11. DosSantos B.P., Valverde J.V., Rohr P., Monticielo O.A., Brenol J.C.T., Xavier R.M., Chies J.A.B. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus 2012, 21:302-309.
12. Fattal I., Shental N., Mevorach D., Anaya J.M., et al. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 2010, 130:337-343.
13. Fumagalli M., Sironi M. Human genome variability, natural selection and infectious diseases. Curr. Opin. Immunol. 2014, 30:9-16.
14. Hur J.W., Shin H.D., Park B.L., Kim S.Y., Bae S.C. Association study of toll like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens 2005, 65:266-270.
15. Krug A., Rothenfusser S., Hornung V., et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:2154-2163.
16. Lee Y.H., Lee H.S., Choi S.J., Ji J.D., Song G.G. Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin. Exp. Rheumatol. 2012, 30:262-265.
17. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006, 6:823-835.
18. Miller S.A., Dykes D.D., Polesky H.F. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
19. Ng M.W., Lau C.S., Chan T.M., Wong W.H.S., Lau Y.L. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology 2005, 44:1456-1457.
20. Ng M.T., Van H.R., Crockett J.C., et al. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori induced gastric disease. Infect. Immun. 2010, 78:1345-1352.
21. Novak N., Yu C.F., Bussmann C., Maintz L., Peng W.M., Hart J., Hagemann T., et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 2007, 62:766-772.
22. Omar A.H., Yasunami M., Yamazaki A., Shibata H., et al. Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malar. J. 2012, 11:168.
23. Panda A.K., Patnaik S.S., Tripathy S., Das B.K. TLR-9 promoter polymorphisms (T-1237C and T-1486C) are not associated with systemic lupus erythematosus: a case control study and meta-analysis. Hum. Immunol. 2013, 74:1672-1678.
24. Panneer D., Antony P.T., Negi V.S. Q222R polymorphism in DNAse I gene is a risk factor for nephritis in South Indian SLE patients. Lupus 2013, 22:996-1000.
25. Petri M., Orbai A.M., Alarcón G.S., Gordon C., Merrill J.T., Fortin P.R., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-2686.
26. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., et al. Toll-like receptor-1, -2 and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12:1-8.
27. Radstake T.R., Franke B., Hanssen S., Netea M.G., Welsing P., Barrera P., Joosten L.A., van Riel P.L., van den Berg W.B. The toll-like receptor 4 Asp299Gly functional variant is associated with de-creased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum. 2004, 50:999-1001.
28. Reich D., Thangaraj K., Patterson N., Price A.L., Singh L. Reconstructing Indian population history. Nature 2009, 461:489-494.
29. Sanchez E., Orozco G., Lopez-Nevot M.A., Jimenez-Alonso J., Martin J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004, 63:54-57.
30. Sarzi-Puttini P., Atzeni F., Iaccarino L., Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005, 38:465-472.
31. Schroder N.W.J., Hermann C., Hamann L., Gobel U.B., Hartung T., Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll like receptor 2 gene detected by a novel allele specific PCR. J. Mol. Med. 2003, 81:368-372.
32. Sean R.C., Mark J.S. Regulation of lupus-related autoantibody production and clinical disease by toll-like receptors. Semin. Immunol. 2007, 19:11-23.
33. Shizuo A., Kiyoshi T. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4:499-511.
34. Snelgrove T., Lim S., Greenwood C., Peddle L., Hamilton S., Inman R., Rahman P. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J. Rheumatol. 2007, 34:368-370.
35. Sobel E.S., Kakkanaiah V.N., Kakkanaiah M., Cheek R.L., Cohen P.L., Eisenberg R.A. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 1994, 152:6011-6016.
36. Sundar K., Jacques S., Gottlieb P., Villars R., et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti dsDNA and anti-Sm antibodies. J. Autoimmun. 2004, 23:127-140.
37. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
38. Tao K., Fujii M., Tsukumo S., Maekawa Y., et al. Genetic variations of toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann. Rheum. Dis. 2007, 66:905-909.
39. Tsui F.W.L., Xi N., Sherry R., Riarh R., Rose B., Tsui H.W., Inman R.D. Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum. 2008, 58:3436-3438.
40. Zhang L., Qin H., Guan X., Zhang K., Liu Z. The TLR9 gene polymorphism and the risk of cancer: evidence from a meta analysis. PLOS ONE 2013, 8:e71785.